Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05169346 · ClinicalTrials.gov registry record · NA
Neurofeedback to Treat Depression
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT05169346: Completed NA study, sponsored by University of Pennsylvania.
NCT05169346 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05169346, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD (60 in R61 phase and 80 in R33 Phase). This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamically modulate task stimuli (in a closed loop) based on this state.
Interventions
- BEHAVIORAL Active Closed Loop Real Time fMRI Neurofeedback
- BEHAVIORAL Sham Closed Loop Real Time fMRI Neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2025-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05169346
The ClinicalTrials.gov registry entry for NCT05169346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Closed Loop Real Time fMRI Neurofeedback is the first listed.
NCT05169346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05169346 about?
NCT05169346 is a clinical study titled "Neurofeedback to Treat Depression". This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD (60 in R61 phase and 80 in R33 Phase). This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a pat...
What is the current status of trial NCT05169346?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2022-05-25. Estimated completion is 2025-06-13.
What interventions are being tested in trial NCT05169346?
The interventions under investigation include: Active Closed Loop Real Time fMRI Neurofeedback (BEHAVIORAL), Sham Closed Loop Real Time fMRI Neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05169346?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.